Breakthrough Highlights From The 2024 National Pharmacovigilance Conference, first price of the poster category
ParticipaciĂłn de PVpharm en Jornadas Nacionales de Farmacovigilancia

Breakthrough Highlights From The 2024 National Pharmacovigilance Conference, first price of the poster category

  • Post published:November 20, 2024

The National Pharmacovigilance Conference is an annual event that brings together experts to discuss the latest developments in drug safety and pharmacovigilance. This year’s event, held in Oviedo, Spain, offered valuable insights on topics such as artificial intelligence in healthcare, innovative reporting methods, and the growing importance of communication in pharmacovigilance. PVpharm was proud to participate, exchanging ideas with industry leaders and exploring new ways to enhance pharmacovigilance practices. National Pharmacovigilance Conference Session Key Highlights from the Conference Artificial Intelligence for Safety and EfficiencyArtificial intelligence (AI) was a key topic this year. Experts discussed how AI tools like diagnostics, predictive…

Continue ReadingBreakthrough Highlights From The 2024 National Pharmacovigilance Conference, first price of the poster category

Isabella Palagiano to participate as speaker in the AEFI Safety in Clinical Trials Training

  • Post published:February 20, 2024

We are happy to announce that Isabella Palagiano will be participating as speaker in the AEFI Safety in Clinical trials Training. The training will take place on 29th February and 5th March and will be held online, please find more information about the training in the link below: https://aefi.org/eventos/seguridad-en-ensayos-clinicos/?mc_cid=b547e1ac35&mc_eid=54a2a50032 During the 29th, Isabella will be talking about several topics related to ICSRs transmission to Eudravigilance, MHAR and FDA. **PVpharm is also organizing in-house training in pharmacovigilance for pharmaceutical companies and CROs, please contact us for further information.**

Continue ReadingIsabella Palagiano to participate as speaker in the AEFI Safety in Clinical Trials Training

José Alberto Ayala Ortiz to participate as speaker in the AEFI Pharmacovigilance in Social Networks Training

  • Post published:November 2, 2023

We are happy to announce that José Alberto Ayala Ortiz, PVpharm's CEO will be participating as speaker in the AEFI Pharmacovigilance in Social Networks Training. The training will take place on Monday 6th November from 16:00 to 19:00, please find more information about the training in the link below: https://aefi.org/eventos/farmacovigilancia-en-la-era-digital/?mc_cid=ddb97c2046&mc_eid=54a2a50032 During the session, José will be talking about several topics related to Pharmacovigilance and handling of safety related information detected in Social Networks.

Continue ReadingJosé Alberto Ayala Ortiz to participate as speaker in the AEFI Pharmacovigilance in Social Networks Training

José Alberto Ayala Ortiz to participate in the AEFI Symposium 2023

  • Post published:June 1, 2023

We are happy to announce that José Alberto Ayala Ortiz, PVpharm's CEO will be participating in one session of the 2023 Pharmacovigilance symposium organized by AEFI. During the session, José will be talking about safety in food or food supplements. Please take a look to the program at this link: https://www.aefi2023.com/

Continue ReadingJosé Alberto Ayala Ortiz to participate in the AEFI Symposium 2023